The Filing Desk

Cytek Biosciences vs PacBio

Cytek Biosciences CTKB · PacBio PACB · Life Sciences Tools & Services

Cytek Biosciences reported revenue of $202 million in fiscal 2025, 1.3 times PacBio's $160 million in fiscal 2025. Cytek Biosciences' revenue grew 0.5% in its latest year, and PacBio's grew 3.9%. Cytek Biosciences had an operating margin of -20.0%, against -346.1% at PacBio. Free cash flow was −$9 million at Cytek Biosciences and −$114 million at PacBio.

Side by side

Cytek BiosciencesPacBio
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$202M$160M
Revenue growth0.5%3.9%
Revenue growth a year, last 5 years210.3%15.2%
Gross margin51.8%28.6%
Operating margin−20.0%−346.1%
Net margin−33.0%−341.5%
Free cash flow−$9M−$114M
Free cash flow margin−4.3%−71.2%
Return on capital—−77.1%
Net debt to EBITDA——
Dividends and buybacks$15M$0M
Change in diluted share count−2.2%4.0%
Last close$5.84$1.96
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score—3 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Cytek BiosciencesPacBio
Operating margin
Percent of revenue
Cytek BiosciencesPacBio
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Cytek BiosciencesPacBio

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cytek Biosciences and PacBio pages.